Nrx pharmaceuticals (nasdaq:nrxp) appoints neuroscience, information technology and medical technology veteran to its board of directors

Dr. dennis mcbride brings extensive experience in neuroscience and its interface with information and medical technology retired at a rank that is the civilian equivalent of a senior flag officer from the united states navy radnor, pa. , june 18, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced that the company has added dr. dennis mcbride to its board of directors.
NRXP Ratings Summary
NRXP Quant Ranking